Peritumoral Lymphatic Microvessel Density Associated with Tumor Progression and Poor Prognosis in Gastric Carcinoma

被引:40
作者
Coskun, Ugur [1 ]
Akyurek, Nalan [2 ]
Dursun, Ayse [2 ]
Yamac, Deniz [1 ]
机构
[1] Gazi Univ Med Sch, Dept Med Oncol, Ankara, Turkey
[2] Gazi Univ Med Sch, Dept Pathol, Ankara, Turkey
关键词
D2-40; lymphangiogenesis; CD31; gastric carcinoma; prognosis; SQUAMOUS-CELL CARCINOMA; GROWTH-FACTOR-C; NODE METASTASIS; BREAST-CANCER; VESSEL DENSITY; INTRATUMORAL LYMPHATICS; FACTOR-A; LYMPHANGIOGENESIS; ANGIOGENESIS; EXPRESSION;
D O I
10.1016/j.jss.2009.03.081
中图分类号
R61 [外科手术学];
学科分类号
100210 [外科学];
摘要
Background. Lymphangiogenesis and angiogenesis are critical processes for tumor growth, invasion, and metastasis, and are crucial for therapeutic strategies. The aim of the present study was to evaluate the clinical significance of lymphangiogenesis and its regulation in gastric carcinomas. Methods. The lymphatic vessel density (LVD) in 65 gastric carcinoma cases was investigated by immunohistochemistry using D2-40 antibody, and evaluated with prognostic parameters. The intratumoral micro-vessel density (MVD), using CD31 antibody, was assessed and correlated with LVD. Results. D2-40 identified peritumoral lymphatics in all cases, and lymphatic vessel density (LVD) ranged from 3 to 19 (median, 5; mean +/- SD, 7.69 +/- 4.67). The peritumoral L'VD significantly correlated with large tumor size (P = 0.0001), lymph node metastasis (P = 0.004), visceral organ metastasis (P = 0.0001), and TNM stage (P = 0.001). Survival was also significantly lower in patients with high LVD tumors than in patients with low LVD tumors (P = 0.04). Among various clinicopathologic characteristics, CD31 expression was associated only with lymph node metastasis (P = 0.001). However, there was no significant correlation between CD31 and D2-40. Conclusion. Our study showed that lymphangiogenesis plays an important role in the progression of gastric carcinoma. Therefore, D2-40, as an indicator for tumor lymphangiogenesis, may serve as a prognostic marker in gastric carcinoma. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:110 / 115
页数:6
相关论文
共 29 条
[1]
Molecular regulation of angiogenesis and lymphangiogenesis [J].
Adams, Ralf H. ;
Alitalo, Kari .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2007, 8 (06) :464-478
[2]
High LYVE-1-positive lymphatic vessel numbers are associated with poor outcome in breast cancer [J].
Bono, P ;
Wasenius, VM ;
Heikkilä, P ;
Lundin, J ;
Jackson, DG ;
Joensuu, H .
CLINICAL CANCER RESEARCH, 2004, 10 (21) :7144-7149
[3]
Tumor lymphangiogenesis - A novel prognostic indicator for cutaneous melanoma metastasis and survival [J].
Dadras, SS ;
Paul, T ;
Bertoncini, J ;
Brown, LF ;
Muzikansky, A ;
Jackson, DG ;
Ellwanger, U ;
Garbe, C ;
Mihm, MC ;
Detmar, M .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (06) :1951-1960
[4]
Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours [J].
Fukunaga, M .
HISTOPATHOLOGY, 2005, 46 (04) :396-402
[5]
GAO P, 2008, CANC LETT, V18, P223
[6]
Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix [J].
Gombos, Z ;
Xu, XW ;
Chu, CS ;
Zhang, PJ ;
Acs, G .
CLINICAL CANCER RESEARCH, 2005, 11 (23) :8364-8371
[7]
Intratumoral lymphatics and lymph node metastases in papillary thyroid carcinoma [J].
Hall, FT ;
Freeman, JL ;
Asa, SL ;
Jackson, DG ;
Beasley, NJ .
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2003, 129 (07) :716-719
[8]
Intratumoral lymphatics and lymphatic invasion are associated with tumor aggressiveness and poor prognosis in renal cell carcinoma [J].
Horiguchi, Akio ;
Ito, Keiichi ;
Sumitomo, Makoto ;
Kimura, Fumihiro ;
Asano, Tomohiko ;
Hayakawa, Masamichi .
UROLOGY, 2008, 71 (05) :928-932
[9]
Lymphangiogenesis and angiogenesis in conventional renal cell carcinoma: Association with vascular endothelial growth factors a to D immunohistochemistry [J].
Iwata, Takahisa ;
Miyata, Yasuyoshi ;
Kanda, Shigeru ;
Nishikido, Masaharu ;
Hayashi, Tornayoshi ;
Sakai, Hideki ;
Kanetake, Hiroshi .
UROLOGY, 2008, 71 (04) :749-754
[10]
Kahn HJ, 2002, LAB INVEST, V82, p39A